Hanxin Lu Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Central Arkansas

faculty

19 h-index 28 pubs 1,558 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Hanxin Lu's research focuses on the development and preclinical characterization of novel immunotherapies. Recent work includes the investigation of VXX-401, a novel anti-PCSK9 vaccine designed to reduce LDL-C levels in non-human primates, with potential applications in cardiovascular disease prevention. Lu also studies active immunotherapies targeting specific biomarkers, such as calcitonin gene-related peptide, for preclinical characterization. Beyond therapeutic development, Lu's research extends to public health, examining the impact of social determinants, lifestyle factors, and air pollution on allergic diseases and comorbidities through multi-state cohort analyses. Additionally, Lu has investigated health information-seeking behaviors among specific demographic groups. Lu holds a h-index of 19 with 1,558 citations across 28 publications and collaborates with researchers including Alexander N. Chen, Michael J. Rubach, and Mark E. McMurtrey at the University of Central Arkansas.

Metrics

  • h-index: 19
  • Publications: 28
  • Citations: 1,558

Selected Publications

  • Preventive Health Care Information Seeking Behaviors among Baby Boomers in Taiwan (2025) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics